Pooling-based Genome-wide Association Study Implicates Gamma-glutamyltransferase 1 (GGT1) Gene in Pancreatic Carcinogenesis
Overview
Gastroenterology
Authors
Affiliations
Background/aims: Knowledge regarding genetic factors that influence pancreatic cancer risk is currently limited. To identify novel pancreatic cancer susceptibility loci, we conducted a two-stage genome-wide association study.
Methods: The Affymetrix Genome-Wide Human SNP Array 6.0 and DNA pooling were used in the screening stage. Twenty-six single-nucleotide polymorphisms (SNPs) were selected for follow-up. These 26 lead SNPs and additionally selected tagSNPs for the regions around the lead SNPs were evaluated by individual genotyping of the pooling population and an independent validation population.
Results: Of the lead SNPs, the strongest association was found with rs4820599 located in the gamma-glutamyltransferase 1 (GGT1) gene. This SNP was significantly associated with pancreatic cancer risk in the validation population and the combined dataset (p(allele-based) = 0.019 and p(allele-based) = 0.003, respectively). Statistically significant associations were also observed with two GGT1 tagSNPs: rs2017869 and rs8135987. Lead SNP rs4820599 is in high linkage disequilibrium (LD; pairwise r(2): 0.69) and tagSNP rs2017869 is in strong LD (pairwise r(2): 0.96) with SNP rs5751901, which has been reported to be associated with increased GGT1 serum levels. GGT is expressed in the pancreas and plays a key role in glutathione metabolism.
Conclusion: Our results suggest that common variation in the GGT1 gene may affect the risk of pancreatic cancer. .
Agawa S, Futagami S, Nakamura K, Habiro M, Kawawa R, Shinagawa Y JGH Open. 2024; 8(10):e70031.
PMID: 39381360 PMC: 11458879. DOI: 10.1002/jgh3.70031.
Sun L, Wu Z, Lin Y, Xu S, Ye Y, Yin W BMC Med Genomics. 2023; 16(1):267.
PMID: 37891571 PMC: 10612355. DOI: 10.1186/s12920-023-01685-7.
Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus.
Azarova I, Polonikov A, Klyosova E Int J Mol Sci. 2023; 24(5).
PMID: 36902173 PMC: 10003739. DOI: 10.3390/ijms24054738.
Waldenmaier M, Schulte L, Schonfelder J, Furstberger A, Kraus J, Daiss N Cancers (Basel). 2022; 14(4).
PMID: 35205822 PMC: 8870073. DOI: 10.3390/cancers14041074.
Precision medicine for pancreatic diseases.
Shelton C, Whitcomb D Curr Opin Gastroenterol. 2020; 36(5):428-436.
PMID: 32740003 PMC: 7748065. DOI: 10.1097/MOG.0000000000000665.